Countdown to APA 2010

Professor of Psychiatry and Pediatrics, Case Western Reserve University, Cleveland, Ohio

Disclosure: Robert L. Findling, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Abbott Laboratories; Addrenex; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Forest Laboratories Inc; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C; Eli Lilly and Company; Neuropharm; Otsuka Pharmaceuticals Co. Ltd; Pfizer Inc; Shire; Supernus Pharmaceuticals; Wyeth Pharmaceuticals Inc.
Served as an advisor or consultant for: Abbott Laboratories; Addrenex; AstraZeneca Pharmaceuticals LP; Biovail Corporation; Bristol-Myers Squibb Company; Forest Laboratories, Inc; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; KemPharm; Eli Lilly and Company; Lundbeck Research USA, Inc; Novartis Pharmaceuticals Corporation; Organon Pharmaceuticals USA Inc; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; sanofi-aventis; Sepracor Inc.; Shire; Solvay Pharmaceuticals, Inc.; Supernus Pharmaceuticals; Validus; Wyeth Pharmaceuticals Inc.
Served on the speakers bureau for: Bristol-Myers Squibb Company; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Shire